GMED Globus Medical Inc

Price (delayed)

$71.89

Market cap

$9.71B

P/E Ratio

121.85

Dividend/share

N/A

EPS

$0.59

Enterprise value

$9.88B

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing ...

Highlights
GMED's equity has surged by 105% year-on-year
Globus Medical's revenue has surged by 78% YoY and by 21% QoQ
The P/E is 173% more than the 5-year quarterly average of 44.5 and 142% more than the last 4 quarters average of 50.2
GMED's quick ratio has dropped by 72% year-on-year and by 53% since the previous quarter

Key stats

What are the main financial stats of GMED
Market
Shares outstanding
135.06M
Market cap
$9.71B
Enterprise value
$9.88B
Valuations
Price to book (P/B)
2.48
Price to sales (P/S)
5.13
EV/EBIT
120.64
EV/EBITDA
37.46
EV/Sales
5.2
Earnings
Revenue
$1.9B
EBIT
$81.91M
EBITDA
$263.79M
Free cash flow
$151.72M
Per share
EPS
$0.59
Free cash flow per share
$1.12
Book value per share
$28.97
Revenue per share
$14.03
TBVPS
$19.24
Balance sheet
Total assets
$4.94B
Total liabilities
$1.02B
Debt
$525.6M
Equity
$3.92B
Working capital
$1.04B
Liquidity
Debt to equity
0.13
Current ratio
2.33
Quick ratio
1.23
Net debt/EBITDA
0.65
Margins
EBITDA margin
13.9%
Gross margin
62.1%
Net margin
3.5%
Operating margin
4.5%
Efficiency
Return on assets
1.5%
Return on equity
1.9%
Return on invested capital
3.8%
Return on capital employed
2%
Return on sales
4.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GMED stock price

How has the Globus Medical stock price performed over time
Intraday
0.2%
1 week
-1.02%
1 month
5.63%
1 year
15.49%
YTD
34.9%
QTD
4.96%

Financial performance

How have Globus Medical's revenue and profit performed over time
Revenue
$1.9B
Gross profit
$1.18B
Operating income
$84.74M
Net income
$66.63M
Gross margin
62.1%
Net margin
3.5%
The net margin has dropped by 81% year-on-year and by 55% since the previous quarter
The company's operating margin has shrunk by 80% YoY and by 47% QoQ
Globus Medical's revenue has surged by 78% YoY and by 21% QoQ
The company's net income has shrunk by 67% YoY and by 46% QoQ

Growth

What is Globus Medical's growth rate over time

Valuation

What is Globus Medical stock price valuation
P/E
121.85
P/B
2.48
P/S
5.13
EV/EBIT
120.64
EV/EBITDA
37.46
EV/Sales
5.2
The P/E is 173% more than the 5-year quarterly average of 44.5 and 142% more than the last 4 quarters average of 50.2
The EPS has dropped by 71% year-on-year and by 46% since the previous quarter
GMED's equity has surged by 105% year-on-year
The stock's P/B is 27% less than its 5-year quarterly average of 3.4 but 24% more than its last 4 quarters average of 2.0
Globus Medical's revenue has surged by 78% YoY and by 21% QoQ
GMED's P/S is 20% lower than its 5-year quarterly average of 6.4 but 16% higher than its last 4 quarters average of 4.4

Efficiency

How efficient is Globus Medical business performance
The ROA has dropped by 85% year-on-year and by 55% since the previous quarter
Globus Medical's return on equity has shrunk by 83% YoY and by 54% QoQ
The return on sales has dropped by 81% year-on-year and by 54% since the previous quarter
GMED's ROIC has dropped by 77% year-on-year and by 46% since the previous quarter

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical financials performed over time
GMED's total assets has surged by 130% year-on-year but it is down by 2.8% since the previous quarter
GMED's quick ratio has dropped by 72% year-on-year and by 53% since the previous quarter
The debt is 87% smaller than the equity
GMED's equity has surged by 105% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.